Study to Assess the Safety and Efficacy of DERMASEAL for the Treatment of Split-Thickness Skin Graft Donor Site Wounds

Conditions: Skin Graft Complications Interventions: Combination Product: DERMASEAL Sponsors: Hobart W. Harris; Vitruvian Medical Devices, Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06134843

Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials